Meteorin-like Levels in Individuals With Periodontitis
Launched by ISTANBUL SAGLIK BILIMLERI UNIVERSITY · May 21, 2020
Trial Information
Current as of May 23, 2025
Completed
Keywords
ClinConnect Summary
Periodontitis is a destructive chronic inflammatory disease that can start with localized inflammatory reactions created by the supporting tissues surrounding the teeth against microorganisms and then result in loss of teeth. Cytokines play an important role in inflammation that occurs in periodontal disease.
Interleukine -1β ( IL-1β ) levels are associated with periodontal destruction in the pathogenesis of periodontal disease. Cytokines such as Interleukine-10 (IL-10) and transforming growth factor- β (TGF-β) have been reported to decrease periodontal disease progression rate.
Gingival ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • systemically healthy
- • individuals who does not have a disease under treatment,
- • individuals without regular systemic medication
- Exclusion Criteria:
- • smoking
- • receiving periodontal treatment in the last 6 months
- • pregnancy
- • menopausal or menstrual period
About Istanbul Saglik Bilimleri University
Istanbul Sağlık Bilimleri University is a prominent academic institution dedicated to advancing healthcare through innovative research and education. As a clinical trial sponsor, the university leverages its expertise in health sciences to facilitate rigorous clinical studies aimed at improving patient outcomes and contributing to the body of medical knowledge. With a commitment to ethical practices and collaboration, Istanbul Sağlık Bilimleri University fosters an environment that encourages scientific inquiry and the translation of research findings into practical applications, thereby enhancing the quality of healthcare both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
İstanbul, Eyalet/Yerleşke, Turkey
Patients applied
Trial Officials
Ayşe Toraman, Dr.
Study Chair
Saglik Bilimleri Universitesi
Serhat Köseoğlu, assoc prof
Study Chair
Saglik Bilimleri Universitesi
Mehmet Sağlam, assoc prof
Study Chair
Izmir Katip Celebi University
Levent Savran, PhD
Study Chair
Izmir Katip Celebi University
Ebru Sağlam, Dr
Principal Investigator
Saglik Bilimleri Universitesi
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials